Stay updated on Etripamil Nasal Spray Safety Study Clinical Trial
Sign up to get notified when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.

Latest updates to the Etripamil Nasal Spray Safety Study Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s footer was updated to display a newer site revision version (moving from v3.5.2 to v3.5.3). This represents a platform/release change and does not alter the study information presented.SummaryDifference0.1%

- Check28 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check85 days agoChange DetectedA new publication citation related to NODE-303 was added to the Publications section, describing a post hoc analysis of self-administered etripamil nasal spray in atrial fibrillation.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.4.2 was added. The government funding lapse notice and the Revision: v3.4.1 entry were removed.SummaryDifference0.2%

Stay in the know with updates to Etripamil Nasal Spray Safety Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.